ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
Cash Flow Under PressureContracting
Percentile Rank36
3Y CAGR-40.8%
5Y CAGR-25.0%
Year-over-Year Change
Cash generated from core business operations
3Y CAGR
-40.8%/yr
vs +78.2%/yr prior
5Y CAGR
-25.0%/yr
Recent deceleration
Acceleration
-118.9pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $192.15M | -84.7% |
| 2024 | $1.26B | +587.1% |
| 2023 | $183.38M | -80.2% |
| 2022 | $924.75M | +292.1% |
| 2021 | $235.86M | -70.8% |
| 2020 | $808.03M | +572.0% |
| 2019 | $120.24M | +31.0% |
| 2018 | $91.81M | -97.7% |
| 2017 | $4.01B | +89.0% |
| 2016 | $2.12B | - |